Also, a mere extraction of overall quantitative features like the PSMA-positive total tumor volume might give a summary of the general prostate cancer development but does not account for varying cancer evolution patterns in the different organs, which can be especially important after a combination of systemic and local therapy. The gene discussed is FOLH1; the disease is Familial prostate cancer.